Tobacco and Public Health - TCSC Indonesia

142
PHARMACOLOGY OF NICOTINE ADDICTION
Corrigall, W.A.(1999). Nicotine self-administration in animals as a dependence model. Nicotine and
Tobacco Research, 1, 11–20.
Ernst, M., Matochik, J. A., Heishman, S. J., Van Horn, J. D., Jons, P. H., Henningfield, J. E., and
London,E.D.(2001). Effect of nicotine on brain activation during performance of a working
memory task. Proceedings of the National Academy of Sciences of the United States of America, 98
(8), 4728–33.
Evans, S. M., Cone, E. J., and Henningfield, J. E. (1996). Arterial and venous cocaine plasma
concentrations in humans: relationships to route of administration, cardiovascular effects and
subjective effects. Journal of Pharmacology and Experimental Therapeutics, 279, (3), 1345–56.
Fant, R. V., Henningfield, J. E., Nelson, R., and Pickworth, W. B. (1999). Pharmacokinetics and
pharmacodynamics of moist snuff in humans. Tobacco Control, 8, 387–92.
Finnegan, J. K., Larson, P. S., and Haag, H. B. (1945). The role of nicotine in the cigarette habit.
Science, 102, 94–6.
Fiore, M. C., Bailey, W. C., Cohen, S. J., et al. (2000). Treating tobacco use and dependence. Clinical
practice guideline. U.S. Department of Health and Human Services. Public Health Service,
Rockville, MD.
Fischman, M. W., and Mello, N. K. (ed.) (1989). Testing for abuse liability of drugs in humans.
NIDA Research Monograph, No. 92. Washington, DC, U.S. Government. Printing Office,
73-100.
Food and Drug Administration (1995). 21 CFR Part 801, et al. Regulations restricting the sale and
distribution of cigarettes and smokeless tobacco products to protect children and adolescents;
proposed rule analysis regarding FDA’s jurisdiction over nicotine-containing cigarettes and
smokeless tobacco products; notice. Federal Register, 60 (155), 41314–792.
Food and Drug Administration (1996). 21 CFR Part 801, et al. Regulations restricting the sale and
distribution of cigarettes and smokeless tobacco to protect children and adolescents; final rule.
Federal Register, 61 (168), 44396–5318.
Foulds, J., Stapleton, J., Bell, N., Swettenham, J., Jarvis, M. J., and Russell, M. A. H. (1997). Mood and
physiological effects of subcutaneous nicotine in smokers and never-smokers. Drug and Alcohol
Dependence, 44, 105–15.
Gawin, F. H., and Kleber, H. D. (1986). Abstinence symptomatology and psychiatric diagnosis in cocaine
abusers, archives of general psychiatry,Vol. 43, pp. 107–13.
Giovino, G. A., Henningfield, J. E., Tomar, S. L., Escobedo, L. G., and Slade, J. (1995). Epidemiology
of tobacco use and dependence. Epidemiologic Reviews, 17 (1), 48–65.
Goldberg, S. R., Spealman, R. D., Risner, M. E., and Henningfield, J. E. (1983). Control of behavior by
intravenous nicotine injections in laboratory animals. Pharmacology Biochemistry and Behavior,
19, 1011–20.
Goldberg, S. R., and Henningfield, J. E. (1988). Reinforcing effects of nicotine in humans and
experimental animals responding under intermittent schedules of IV drug injection.
Pharmacology Biochemistry and Behavior, 30, 227–34.
Goldstein, A. (1994). Addiction: from biology to drug policy.W.H. Freeman and Company, New York.
Griffiths, R. R., Bigelow, G. E., and Henningfield, J. E. (1980). Similarities in animal and human
drug-taking behavior. In: Advances in substance abuse (ed. N. K. Mello), pp. 1–90. JAI Press, Inc.,
Greenwich, Connecticut.
Gritz, E. R. (1980). Smoking behavior and tobacco use. Advances in Substance Abuse, 1, 91–158.
Heishman, S. J., Taylor, R. C., and Henningfield, J. E. (1994). Nicotine and smoking: a review
of effects on human performance. Experimental and Clinical Psychopharmacology, 2 (4),
345–95.